Portal de Periódicos da CAPES

The Danish Head and Neck Cancer Group (DAHANCA) 2020 radiotherapy guidelines

2020; Elsevier BV; Volume: 151; Linguagem: Inglês

10.1016/j.radonc.2020.07.037

1879-0887

Kenneth Jensen, Jeppe Friborg, C.R. Hansen, Eva Samsøe, Jørgen Johansen, Maria Andersen, B. Smulders, Elo Andersen, Martin Skovmos Nielsen, Jesper Grau Eriksen, Jørgen Breede Baltzer Petersen, U.V. Elstrøm, Anne I. S. Holm, Mohammed Farhadi, Morten Hjartdal Morthorst, P.S. Skyt, Jens Overgaard, Cai Grau,

Tracheal and airway disorders

The Danish Head and Neck Cancer Group (DAHANCA) was founded in 1976. Over the years the group successfully conducted clinical trials and has developed national guidelines for all aspects of the treatment of head and neck cancer. The first national recommendations for radiotherapy was included as an appendix to the DAHANCA 2 and DAHANCA 5 protocols [1,2] in 1979 and 1986, respectively. A thorough description of doses and treatment fields were in 1991 included in the large DAHANCA 6&7 randomized trial [3] and later in the DAHANCA 9 protocol [4].